Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Cash flows from operating activities:    
Net loss $ (5,919,796) $ (2,670,849)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest expense - debt discount 29,623 45,625
Interest expense - debt discount, related party 4,819
Stock-based compensation to employees and consultants 2,020,006 1,160,370
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 55,116 475,904
Accounts payable and accrued expenses 546,217 336,108
Net cash used in operating activities (3,268,834) (648,023)
Cash flows from investing activities:    
Proceeds from repayments of notes receivable - related party 100,915
Net cash provided by investing activities 100,915
Cash flows from financing activities:    
Proceeds from the issuance of common stock and warrants - related party, net 2,000,000
Proceeds from stock option exercise 800
Advances from related party payable 668
Proceeds from note payable 62,110
Proceeds from note receivable for common stock – related party 99,905
Proceeds from convertible note payable 250,000
Proceeds from convertible note payable, related party 50,000
Proceeds from initial public offering, net of underwriters' discounts and commissions and issuance costs 12,911,456
Net cash provided by financing activities 14,912,256 462,683
Net increase (decrease) in cash 11,643,422 (84,425)
Cash at beginning of period 1,929,270 90,285
Cash at end of period 13,572,692 5,860
Non-cash financing activities:    
Fair value of warrants issued in connection with initial public offering 461,877
Fair value of warrants issued in connection with convertible notes payable, related party 4,799,742 14,300
Fair value of warrants issued in connection with convertible notes payable $ 78,642